Global Disposable Syringes Market - 2022-2029
Market Overview
Disposable Syringes Market is estimated to reach at a CAGR of 6.5% during the forecast period (2022-2029).
Surgical glues (also called surgical sealants or adhesives) are used after a surgery or traumatic injury to bind together external or internal tissue. Surgical glues can be used in conjunction with or as an alternative to sutures and staples; they use a chemical bond to hold tissue together for healing or serve as a barrier to stop bodily fluids flow.
Advancements in the Disposable Syringes market were primarily aimed at addressing the limitations of traditional wound sealing techniques. Furthermore, due to surgical glue's favorable biological and physical properties, more surgeons are using this technique to seal wounds. Disposable Syringes is derived from several natural biopolymers, including gelatin, collagen, chitosan, albumin, and fibrin. A syringe designed for one-time use and is discarded after the use is called a disposable syringe. Furthermore, a syringe is defined as a sterile cylindrical medical instrument that has a thin hollow needle at the end. Besides, this device acts as a pump, which is used to draw therapeutic liquid formulations from vials and deliver them to a patient's bloodstream. However, within more modern times, the disposable syringe has risen in popularity over the traditional reusable syringe. The primary difference being that a disposable syringe is intended for one-time use and is then disposed of, typically into a contamination unit.
Market Dynamics
The global disposable syringes market growth driven by certain factors such by increasing number of activities by various NGOs that create awareness for disposable syringes, the need to control the spread of diseases like HIV, and the rising demand for injectable drugs.
Increasing incidences of road accidents, is expected to drive the global disposable syringes market during the forecast period
There has been a marked increase in the use of injectable drugs, primarily due to the lack of bioavailability in conventional drug delivery methods. Many orally administered drugs are subject to decomposition during the first-pass metabolism, which renders them ineffective by the time they reach the systemic circulation. On the other hand, injectable drugs directly enter the systemic circulation and provide the desired effect with a quicker onset of action. Furthermore, there are rising cases of needlestick injuries that are driving the demand for safety syringes. These advantages are also responsible for the increased adoption of injectable drugs and the global disposable syringes market's consequent growth. Furthermore, the increasing demand for vaccines is expected to drive syringes' sales, particularly disposable syringes, in the developing regions of the world.
The sustained growth of the injectable drugs sector, which primarily includes biologics, is the major factor driving the global disposable syringes market. More than 60% of drugs in clinical development are biologics. This indicates the strong growth of the biologics market. In turn, this is expected to boost the disposable syringes market. The rise in demand for point-of-care administration and technological advancements in the manufacturing of disposable syringes fuel the global disposable syringes market.
Ground breaking innovations such as introducing two-step disposable auto-injector devices are bolstering the growth of the global disposable syringes market. Companies in the market for disposable syringes are increasing efforts to introduce devices that cater to different drugs' viscosities. They are increasing focus to deliver design improvements in devices that eliminate the need for customizing system components. Novel two-step disposable autoinjector devices are overcoming challenges of breakage and incompatibility associated with poorly integrated systems.
Strict regulations associated with Disposable Syringes hampering the growth of the Disposable Syringes market
Disposable Syringes has several limitations associated with its usability and safety, such as allergic reactions, wound dehiscence, and skin infections. Besides, it is categorized as class II by the FDA and class B by the Drugs and Cosmetics Acts (1940) in India, making it a little risky and thus requiring clinical trials and further leading to legal complexities. The safety, quality, and performance of these materials are necessary facets requiring stringent evaluation for public health, which lead to complex and strict regulations for their affiliation. Therefore, these factors are hampering the growth of the Disposable Syringes market.
Industry Analysis
The global Disposable Syringes market provides in-depth analysis of the market based on various industry factors such as porter’s five force analysis, supply chain analysis, regulatory analysis, pricing analysis, product analysis etc.
Segment Analysis/B>
The cyanoacrylates segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The cyanoacrylates segment held the largest market share. Cyanoacrylate is a sticky substance found in many types of glue. Cyanoacrylate poisoning occurs when someone swallows this substance or gets it on their skin. Once the applicator is initiated and the cyanoacrylate adhesive is applied to moist tissue, the polymerization process occurs. A feature of our cyanoacrylate devices is that only a low heat level is generated when this polymerization starts. Consequently, the patient does not experience the stinging or burning sensation that occurs with some competitor products.
Cyanoacrylate glue is biocompatible and does not need removal as it naturally slough off the skin as part of the natural wound healing process. Cyanoacrylate properties, namely fast-setting, high tensile strength polymers that bind with the skin's surface and are flexible, durable, waterproof, and transparent on the setting, make cyanoacrylate ideal for wound closure and skin barrier products. Cyanoacrylates provide a non-traumatic means of wound closure and enhance the patient experience over conventional wound closure methods. They are commonly used to close laparoscopic incisions and are much stronger than fibrin sealants and sutures. Cyanoacrylates are waterproof, flexible, and require no dressing on the wound.
Geographical Analysis
North America region holds the largest market share of the global Disposable Syringes market
North America region is dominating the global Disposable Syringes market accounted for the largest market share in 2021, owing to advanced healthcare infrastructure and experienced professionals in this region which leads to higher adoption of Disposable Syringes in hospitals, specialty clinics, and diagnostic centers. Also, growing awareness of the benefits of non-invasive medical aesthetic treatments is also boosting the growth of the market. The number of breast augmentation and liposuction procedures in the United States has always been high.
Canada's aesthetic device market is a highly diversified and export-oriented industry that manufactures equipment and supplies where purchasers include Canadian and international hospitals, physician’s offices, laboratories, clinics, as well as patients (through direct purchases). The aesthetic device sector is populated with companies driven by product innovation. The industry is able to draw on world-class innovative research being conducted in Canadian universities, research institutes, and hospitals, some of which have been spun-off into Canadian medical device companies. Around 10% of Canada’s medical device companies have spun off from Canadian research organizations.
Competitive Landscape
The global Disposable Syringes market is fragmented with the presence of a large number of market players. Some of the major players contributing to the growth of the Disposable Syringes market are Allergan Plc., Bausch Health Companies Inc., Cutera Palomar Medical Technologies, Cynosure Inc., Fosun International Ltd., Fotona Inc., Lutronic Inc., Sciton Inc., among others. Rising awareness toward aesthetic-based skin and body rejuvenation lasers and energy devices have increased the revenue opportunities for leading manufacturers to invest in the Disposable Syringes market.
The key players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Disposable Syringes market globally. For instance,
In August 2020, the US-based Sensus Healthcare has acquired mobile aesthetic laser companies Aesthetic Mobile Laser Services and Aesthetic Laser Partners in Florida, US. The transactions are expected to bring in approximately $1m in revenues over the next 12 months.
In May 2020, AbbVie has completed the acquisition of Allergan. AbbVie planning to launch Allergan Aesthetics, a global subsidiary under the umbrella of the AbbVie-Allergan merger.
In November 2019, Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT, and gynecology from XIO. The transaction values Lumenis at an enterprise value of over $1 billion.
Key Companies to Watch
Allergan Plc
Overview: Allergan Plc is a bold, global pharmaceutical company. It is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Product Portfolio: CoolTone Device- The CoolTone device is FDA-cleared for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen. CoolTone is also FDA-cleared for strengthening, toning, and firming of buttocks and thighs.
The global Disposable Syringes market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook